|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Novo Holdings A/S
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In
Common stock purchase or sale:
| Transaction Date |
Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2017-10-10 Sale |
2017-10-12 5:21 pm |
KalVista Pharmaceuticals Inc. | KALV | Novo Holdings A/S 10% Owner |
2,725,283 | $9.64 | $26,271,182 | 2,311,927 (Direct) |
View |
| 2017-09-13 Sale(A) |
2017-09-18 7:04 pm |
KalVista Pharmaceuticals Inc. | KALV | Novo Holdings A/S 10% Owner |
176,644 | $7.212 | $1,273,956 | 2,876,027 (Direct) |
View |
| 2017-09-13 Sale |
2017-09-15 7:18 pm |
KalVista Pharmaceuticals Inc. | KALV | Novo Holdings A/S 10% Owner |
176,647 | $7.212 | $1,273,980 | 2,876,027 (Direct) |
View |
| 2017-08-23 Sale |
2017-08-25 7:17 pm |
HTG MOLECULAR DIAGNOSTICS INC | HTGM | Novo Holdings A/S 10% Owner |
1,149,813 | $1.814 | $2,085,985 | 1,102,651 (Direct Indirect) |
View |
| 2017-08-18 Sale |
2017-08-22 7:25 pm |
HTG MOLECULAR DIAGNOSTICS INC | HTGM | Novo Holdings A/S 10% Owner |
80,586 | $2.072 | $166,988 | 1,225,085 (Direct) |
View |
| 2017-08-21 Sale |
2017-08-21 5:11 pm |
ANAPTYSBIO INC | ANAB | Novo Holdings A/S 10% Owner |
356,300 | $21.1 | $7,518,251 | 1,936,604 (Direct) |
View |
| 2017-08-14 Sale |
2017-08-16 4:56 pm |
ANAPTYSBIO INC | ANAB | Novo Holdings A/S 10% Owner |
178,600 | $21.16 | $3,778,481 | 2,436,332 (Direct) |
View |
| 2017-08-04 Sale |
2017-08-08 6:08 pm |
ANAPTYSBIO INC | ANAB | Novo Holdings A/S 10% Owner |
491,294 | $21.12 | $10,377,406 | 2,952,527 (Direct) |
View |
| 2017-08-01 Sale |
2017-08-03 5:21 pm |
ANAPTYSBIO INC | ANAB | Novo Holdings A/S 10% Owner |
70,706 | $23.31 | $1,647,947 | 3,009,949 (Direct) |
View |
| 2017-07-24 Sale |
2017-07-26 7:22 pm |
Apollo Endosurgery Inc. | APEN | Novo Holdings A/S 10% Owner |
50,130 | $6.897 | $345,766 | 1,334,772 (Direct) |
View |
| 2017-06-23 Purchase |
2017-06-27 4:52 pm |
Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner |
20,000 | $10.95 | $219,000 | 3,244,046 (Direct) |
View |
| 2017-06-13 Sale |
2017-06-14 4:39 pm |
REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner |
61,000 | $25.11 | $1,531,926 | 642,405 (Direct) |
View |
| 2017-06-08 Sale |
2017-06-12 6:12 pm |
REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner |
222,503 | $25.71 | $5,719,779 | 746,297 (Direct) |
View |
| 2017-06-05 Sale |
2017-06-07 7:01 pm |
REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner |
89,497 | $28.24 | $2,527,394 | 942,467 (Direct) |
View |
| 2017-05-10 Sale |
2017-05-11 6:00 pm |
Apollo Endosurgery Inc. | APEN | Novo A/S 10% Owner |
105,000 | $5.626 | $590,703 | 1,455,472 (Direct) |
View |
| 2017-01-31 Purchase |
2017-02-01 4:22 pm |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
50,000 | $15 | $750,000 | 3,033,504 (Direct) |
View |
| 2016-12-14 Sale |
2016-12-16 6:29 pm |
Ophthotech Corp. | OPHT | Novo A/S 10% Owner |
3,610,487 | $4.874 | $17,598,385 | 1,405,487 (Direct) |
View |
| 2016-10-31 Purchase |
2016-11-02 4:54 pm |
Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner |
246,154 | $13 | $3,200,002 | 2,031,562 (Direct) |
View |
| 2016-10-25 Purchase |
2016-10-26 4:46 pm |
iRhythm Technologies Inc. | IRTC | Novo A/S 10% Owner |
100,000 | $17 | $1,700,000 | 2,124,448 (Direct) |
View |
| 2016-09-09 Purchase |
2016-09-13 11:48 am |
CoLucid Pharmaceuticals Inc. | CLCD | Novo A/S 10% Owner |
100,000 | $20 | $2,000,000 | 3,156,563 (Direct) |
View |
| 2016-07-11 Sale |
2016-07-13 6:26 pm |
Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner |
59,067 | $12.02 | $710,118 | 1,914,541 (Direct) |
View |
| 2016-07-05 Sale |
2016-07-07 6:46 pm |
Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner |
92,119 | $12.2 | $1,124,131 | 2,016,691 (Direct) |
View |
| 2016-06-28 Sale |
2016-06-30 6:01 pm |
Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner |
66,814 | $13.04 | $870,941 | 2,073,022 (Direct) |
View |
| 2016-06-06 Sale |
2016-06-07 5:08 pm |
Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner |
187,500 | $10.37 | $1,943,906 | 2,093,905 (Direct) |
View |
| 2016-06-01 Purchase |
2016-06-02 4:17 pm |
REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner |
750,000 | $11 | $8,250,000 | 750,000 (Direct) |
View |
| 2016-05-24 Sale |
2016-05-25 5:17 pm |
Ophthotech Corp. | OPHT | Novo A/S 10% Owner |
1,300,000 | $49 | $63,700,000 | 3,610,489 (Direct) |
View |
| 2016-05-12 Purchase |
2016-05-16 5:01 pm |
Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner |
70,000 | $10 | $700,000 | 3,224,046 (Direct) |
View |
| 2016-03-29 Purchase |
2016-03-30 1:07 pm |
Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner |
666,666 | $15 | $9,999,990 | 3,154,046 (Direct) |
View |
| 2016-03-02 Sale |
2016-03-04 6:34 pm |
Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner |
190,000 | $6.8 | $1,292,086 | 2,361,405 (Direct) |
View |
(A) Indicate amendment filing.
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported Date |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2017-06-22 Sale |
2017-06-23 4:34 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Novo Holdings A/S 10% Owner |
1,200,000 | $25 | 1,201,969 (Direct) |
View |
| 2017-01-31 Conversion |
2017-02-01 4:22 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
1,428,571 | $0 | 3,033,504 (Direct) |
View |
| 2017-01-31 Conversion |
2017-02-01 4:22 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
486,820 | $0 | 3,033,504 (Direct) |
View |
| 2017-01-31 Conversion |
2017-02-01 4:22 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
312,986 | $0 | 3,033,504 (Direct) |
View |
| 2017-01-31 Conversion |
2017-02-01 4:22 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
673,454 | $0 | 3,033,504 (Direct) |
View |
| 2017-01-31 Exercise |
2017-02-01 4:22 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
81,673 | $0 | 3,033,504 (Direct) |
View |
| 2017-01-31 Conversion |
2017-02-01 4:22 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
1,428,571 | $0 | 3,033,504 (Direct) |
View |
| 2017-01-31 Conversion |
2017-02-01 4:22 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
486,820 | $0 | 3,033,504 (Direct) |
View |
| 2017-01-31 Conversion |
2017-02-01 4:22 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
312,986 | $0 | 3,033,504 (Direct) |
View |
| 2017-01-31 Conversion |
2017-02-01 4:22 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
673,454 | $0 | 3,033,504 (Direct) |
View |
| 2017-01-31 Exercise |
2017-02-01 4:22 pm |
N/A 2018-11-04 |
ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner |
117,235 | $4.55 | 3,033,504 (Direct) |
View |
| 2016-10-31 Conversion |
2016-11-02 4:54 pm |
N/A N/A |
Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner |
924,970 | $0 | 2,031,562 (Direct) |
View |
| 2016-10-31 Conversion |
2016-11-02 4:54 pm |
N/A N/A |
Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner |
860,438 | $0 | 2,031,562 (Direct) |
View |
| 2016-10-31 Conversion |
2016-11-02 4:54 pm |
N/A N/A |
Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner |
924,970 | $0 | 2,031,562 (Direct) |
View |
| 2016-10-31 Conversion |
2016-11-02 4:54 pm |
N/A N/A |
Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner |
860,438 | $0 | 2,031,562 (Direct) |
View |
| 2016-10-25 Conversion |
2016-10-26 4:46 pm |
N/A N/A |
iRhythm Technologies Inc. | IRTC | Novo A/S 10% Owner |
2,007,449 | $0 | 2,124,448 (Direct) |
View |
| 2016-10-25 Conversion |
2016-10-26 4:46 pm |
N/A N/A |
iRhythm Technologies Inc. | IRTC | Novo A/S 10% Owner |
2,007,449 | $0 | 2,124,448 (Direct) |
View |
| 2016-06-01 Conversion |
2016-08-05 11:41 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner |
215,794 | $0 | 2,401,969 (Direct) |
View |
| 2016-06-01 Conversion |
2016-08-05 11:41 am |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner |
215,794 | $0 | 2,401,969 (Direct) |
View |
| 2016-03-29 Conversion |
2016-03-30 1:07 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner |
2,130,492 | $0 | 3,154,046 (Direct) |
View |
| 2016-03-29 Conversion |
2016-03-30 1:07 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner |
356,888 | $0 | 3,154,046 (Direct) |
View |
| 2016-03-29 Conversion |
2016-03-30 1:07 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner |
2,130,492 | $0 | 3,154,046 (Direct) |
View |
| 2016-03-29 Conversion |
2016-03-30 1:07 pm |
N/A N/A |
Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner |
356,888 | $0 | 3,154,046 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Mon, 21 May 2018 04:15:25 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |